Kalisiyumu ya Rosuvastatin

Ibisobanuro bigufi:

Izina rya API Kwerekana Ibisobanuro DMF yo muri Amerika EU DMF CEP
Kalisiyumu ya Rosuvastatin Hypercholesterolemia Mu nzu / CEP 20705 CEP2015-240


Ibisobanuro birambuye

Ibiranga ibicuruzwa

KUBONA UMUSARURO

瑞舒 伐 他 汀 钙 Kalisiyumu ya Rosuvastatin 147098-20-2 Mu nzu / CEP
RSM (Crystal) 147118-40-9 Mu nzu
RSM (Crude) 147118-40-9 Mu nzu
RSP - Mu nzu
RS-8 147118-36-3 Mu nzu
RS-8-1 147118-37-4 Mu nzu
TP-8 131466-61-0 Mu nzu
TP-11 147118-35-2 Mu nzu
TP-13 147118-39-6 Mu nzu
RS-10 289042-12-2 Mu nzu
RS-11 355806-00-7 Mu nzu

Ibisobanuro

Kalisiyumu ya Rosuvastatin (BANM, JAN, USAN) izwi nka Rosuvastatin muri Amerika.hamwe na HMG-CoA irwanya reductase inhibitor hamwe na IC50 ya 11 nM [1].Kalisiyumu ya Rosuvastatin ihagarika imbaraga za ether-yumuntu ujyanye na gene (HERG) hamwe na IC50 ya 195 nM, gutinda kwimitsi yumutima, bityo bigatuma ibikorwa byigihe kirekire (APDs) bikosora intera ya QT (QTc) [2].Kalisiyumu ya Rosuvastatin igabanya imvugo ya HERG ikuze no gukorana kwa poroteyine yubushyuhe 70 (Hsp70) hamwe na poroteyine ya HERG.Kalisiyumu ya Rosuvastatin igira akamaro kanini mu kugabanya cholesterol ya lipoproteine ​​(LDL) nkeya, triglyceride, hamwe na poroteyine C-itera imbaraga [3].

Andi makuru yerekeye amasezerano yo kwita ibiyobyabwenge: Amazina Mpuzamahanga.

Icyitonderwa cyingenzi: Ububiko mpuzamahanga bwibiyobyabwenge biri mubisohoka BETA.Ibi bivuze ko bikiri mu majyambere kandi birashobora kuba birimo amakosa.Ntabwo igenewe gusimburwa nubuhanga no guca imanza kwa muganga, umufarumasiye cyangwa undi mwuga wubuzima.Ntibikwiye kumvikana kwerekana ko gukoresha imiti iyo ari yo yose mugihugu icyo aricyo cyose bifite umutekano, bikwiye cyangwa byiza kuri wewe.Baza inzobere mu buvuzi mbere yo gufata imiti iyo ari yo yose.

Muri Amerika, Rosuvastatin (sisitemu ya rosuvastatin) ni umunyamuryango wa statin yo mu rwego rw’ibiyobyabwenge kandi ikoreshwa mu kuvura Atherosclerose, Cholesterol, Cholesterol - Heterozygous Familial, Cholesterol - Familial Homozygous, Hyperlipoproteinemia, Hyperlipoproteinemia Hyperlipoproteinemia IIb - Kuzamura LDL VLDL, Hyperlipoproteinemia Ubwoko bwa III - Hejuru ya beta-VLDL IDL, Hyperlipoproteinemia Ubwoko bwa IV - VLDL, Hypertriglyceridemia no Kurinda Indwara z'umutima.

Amavu n'amavuko

Guhitamo, guhatanira inhibitori ya HMG-CoA reductase, ibyo nabyo birwanya antilipemic.

 

Ububiko

Ifu

-20 ° C.

Imyaka 3

4 ° C.

Imyaka 2
Mubishobora

-80 ° C.

Amezi 6

-20 ° C.

Ukwezi

Imiterere yimiti

Rosuvastatin Calcium

CERTIFICATE

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

Gucunga neza

Quality management1

Icyifuzo18Imishinga yo gusuzuma ireme ryemejwe4, na6imishinga iremezwa.

Quality management2

Sisitemu mpuzamahanga yo gucunga neza ubuziranenge yashyizeho urufatiro rukomeye rwo kugurisha.

Quality management3

Igenzura ryiza rinyura mubuzima bwose bwibicuruzwa kugirango hamenyekane ingaruka nziza nubuvuzi.

Quality management4

Itsinda ryumwuga ushinzwe kugenzura ibikorwa byujuje ubuziranenge mugihe cyo gusaba no kwiyandikisha.

Gucunga UMUSARURO

cpf5
cpf6

Koreya Countec Amacupa yo gupakira

cpf7
cpf8

Tayiwani CVC Icupa ryuzuye

cpf9
cpf10

Ubutaliyani CAM Ubuyobozi bwo gupakira

cpf11

Imashini yo Kudage Fette

cpf12

Ubuyapani Viswill Tablet Detector

cpf14-1

Icyumba cyo kugenzura DCS

UMUFATANYABIKORWA

Ubufatanye mpuzamahanga
International cooperation
Ubufatanye mu ngo
Domestic cooperation

  • Mbere:
  • Ibikurikira:

  • Andika ubutumwa bwawe hano hanyuma utwohereze

    Ibyiciro byibicuruzwa